A major shift in stroke care is underway as tenecteplase outperforms alteplase. This new treatment could redefine recovery ...

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy ...

BioCardia (BCDA) announced completion of source data verification and freezing of primary outcomes data in the double-blind randomized ...

The sickle cell treatments available before Casgevy focused on symptom management such as reducing the frequency of ...

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy (HIE -- a type of brain damage caused by oxygen loss -- offers no benefits ...

Whole-body hypothermia within hours of birth failed to improve outcomes in preterm infants less than 36 weeks' gestational ...

Circulation issues can be visible if they affect the legs or feet. Symptoms may be invisible but cause internal sensations.

Ocugen (OCGN) announced that alignment has been reached with the FDA to move forward with a Phase 2/3 pivotal confirmatory clinical trial for ...

The following is a summary of “Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion,” published in the February ...

Leading Spanish neuroradiologists presented a unique multicentre registry to boost stroke treatment at the 12th Triángulo ...